Kanako Mamishin

Kashiwa, 2778577, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma.

Efficacy of perioperative pembrolizumab for triple-negative breast cancer with apocrine feature or metaplastic carcinoma.

Journal: The oncologist

Published: January 20, 2026

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

The Impact of Carboplatin Dosing Design Using Adjusted Serum Creatinine on Carboplatin Plus Paclitaxel Therapy for Ovarian Cancer.

Journal: Cancer medicine

Published: February 09, 2024

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.

Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.

Journal: Scientific reports

Published: April 17, 2023

The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.

The impact of the COVID-19 pandemic on perioperative chemotherapy for breast cancer.

Journal: Cancer medicine

Published: January 30, 2023

Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study.

Clinical features of CDK4/6 inhibitor-related interstitial lung disease in patients with breast cancer: a case series study.

Journal: Japanese journal of clinical oncology

Published: July 03, 2022

Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer.

Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer.

Journal: Anticancer research

Published: May 06, 2022

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.

Journal: Frontiers in oncology

Published: March 17, 2022

Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis.

Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis.

Journal: Anticancer research

Published: October 07, 2021

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.

The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.

Journal: Breast (Edinburgh, Scotland)

Published: February 10, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026